Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Aethlon Board Member Resigns to Support Nasdaq Listing Application - Medical Product Outsourcing
Financial & Business, People, Regulatory

Aethlon Board Member Resigns to Support Nasdaq Listing Application

Nasdaq requires a majority of independent directors.

Richard Tullis, M.D., has resigned from the board of San Diego, Calif.-based Aethlon Medical Inc. in order to support the company’s application to list on the Nasdaq capital market. Nasdaq corporate governance rules state that a listed company’s board of directors is required to have a majority of independent directors.  Prior to the resignation of Tullis, Aethlon’s board was comprised of an equal number of inside and outside directors. Tullis will continue in his position as the company’s chief science officer.

Aethlon previously disclosed that it had submitted an application to Nasdaq to request that its common stock be approved for listing on the Nasdaq capital market.  Nasdaq has not yet approved the company’s listing application.

“I have enjoyed my role as a director over the years at Aethlon Medical and look forward to continuing to contribute to the company in my ongoing position as chief science officer,” Tullis said.

Aethlon Medical creates affinity biofiltration devices to treat life-threatening diseases

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters